Mayo Clinic: Esophagitis trials

The registry lists 25 Esophagitis studies with Mayo Clinic as lead sponsor. 0 are open to participants now and 9 have results posted.

Early Phase 1 2Phase 1 3Phase 2 4Phase 3 1Phase 4 2No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Antihistamines in Eosinophilic EsophagitisTerminatedNCT04248712Phase 2Results posted
• Cytosponge and Dietary Therapy in EoECompletedNCT02599558Not applicableResults posted
• Value of Patch Testing in Direct Diet Therapy for Eosinophilic EsophagitisCompletedNCT02227836Not applicableResults posted
• Mucosal Impedance and Eosinophilic EsophagitisCompletedNCT01953575Not applicableResults posted
• Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty AcidsCompletedNCT01733147Phase 4Results posted
• Cytosponge Protocol IRB 11-006429TerminatedNCT01585103Not applicableResults posted
• Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?CompletedNCT01093755Phase 4Results posted
• The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic EsophagitisCompletedNCT00728481Phase 2/3Results posted
• Topical Steroid Treatment for Eosinophilic EsophagitisCompletedNCT00275561Phase 2Results posted
• Eating With Eosinophilic Esophagitis (EoE)CompletedNCT03581838
• MRI to Assess Fibrosis in Eosinophilic Esophagitis PatientsTerminatedNCT03446118Not applicable
• Short Duration 6Fed Sponge For EoE PatientsWithdrawnNCT03354221Not applicable
• Natural History of Eosinophilic EsophagitisCompletedNCT03290482
• Sponge and Eosinophil Peroxidase (EPO) StainingCompletedNCT03078023Not applicable
• Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE)CompletedNCT02995395
• Food Antigen in Eosinophilic EsophagitisCompletedNCT02434705
• The Effect of Sucralfate Slurry in Patients With Eosinophilic EsophagitisCompletedNCT02353078Early Phase 1
• Esophageal Absorption in EoETerminatedNCT02314455Not applicable
• Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE)CompletedNCT01929824
• Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?CompletedNCT01865825
• CYP2C19 Genotype Predictor of Gastric Acid SuppressionWithdrawnNCT01824199Early Phase 1
• Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis PatientsCompletedNCT01641913Phase 1
• Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic EsophagitisWithdrawnNCT01479231Phase 1/2
• Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed EsophagitisCompletedNCT00586963
• Trial of Montelukast in Eosinophilic EsophagitisCompletedNCT00511316Phase 1